HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Identification of inositol polyphosphate 4-phosphatase type II as a novel tumor resistance biomarker in human laryngeal cancer HEp-2 cells.

Abstract
Although tumor resistance remains a significant impediment to successful radiotherapy, associated regulatory markers and detailed molecular mechanisms underlying this phenomenon are not well defined. In this study, we identified inositol polyphosphate 4-phosphatase type II (INPP4B) as a novel marker of radioresistance by systematically analyzing Unigene libraries of laryngeal cancer. INPP4B was highly expressed in radioresistant laryngeal cancer cells and was induced by treatment with either radiation or anticancer drugs in various types of cancer cells. Ectopic INPP4B overexpression increased radioresistance and anticancer drug resistance by suppressing apoptosis in HEp-2 cells. Conversely, INPP4B depletion with small interfering RNA resensitized HEp-2 as well as A549 and H1299 cells to radiation- and anticancer drug-induced apoptosis. Furthermore, radiation-induced INPP4B expression was blocked by inhibition of extracellular signal-regulated kinase (ERK). INPP4B depletion significantly attenuated radiation-induced increases in Akt phosphorylation, indicating an association of INPP4B-mediated radioresistance with Akt survival signaling. Taken together, our data suggest that ERK-dependent induction of INPP4B triggers the development of a tumor-resistance phenotype via Akt signaling and identify INPP4B as a potentially important target molecule for resolving the radioresistance of cancer cells.
AuthorsJae-Sung Kim, Hong Shik Yun, Hong-Duck Um, Jong Kuk Park, Kee-Ho Lee, Chang-Mo Kang, Su-Jae Lee, Sang-Gu Hwang
JournalCancer biology & therapy (Cancer Biol Ther) Vol. 13 Issue 13 Pg. 1307-18 (Nov 2012) ISSN: 1555-8576 [Electronic] United States
PMID22895072 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Antineoplastic Agents
  • Biomarkers, Tumor
  • Proto-Oncogene Proteins c-akt
  • Extracellular Signal-Regulated MAP Kinases
  • Phosphoric Monoester Hydrolases
  • phosphatidylinositol-3,4-bisphosphate 4-phosphatase
Topics
  • Antineoplastic Agents (pharmacology)
  • Apoptosis (drug effects, genetics, radiation effects)
  • Biomarkers, Tumor (biosynthesis, genetics, metabolism)
  • Cell Line, Tumor
  • Drug Resistance, Neoplasm
  • Extracellular Signal-Regulated MAP Kinases (genetics, metabolism)
  • HCT116 Cells
  • Humans
  • Laryngeal Neoplasms (drug therapy, enzymology, genetics, radiotherapy)
  • MCF-7 Cells
  • Phosphoric Monoester Hydrolases (biosynthesis, genetics, metabolism)
  • Phosphorylation (drug effects, radiation effects)
  • Proto-Oncogene Proteins c-akt (genetics, metabolism)
  • Radiation Tolerance

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: